The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Dynin P.S.

Kirov Military Medical Academy

Litvinenko I.V.

Kirov Military Medical Academy

Frunza D.N.

S.M. Kirov Military Medical Academy

Ruban A.V.

S.M. Kirov Military Medical Academy

Higher-level ambulation disorders in Parkinson’s disease

Authors:

Dynin P.S., Litvinenko I.V., Frunza D.N., Ruban A.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(11‑2): 32‑38

DOI: 10.17116/jnevro202512511232

Read: 889 times

Buy for 300₽
Contact the author
Table of contents

HIGHER-LEVEL AMBULATION DISORDERS IN PARKINSON’S DISEASE
HIGHER-LEVEL AMBULATION DISORDERS IN PARKINSON’S DISEASE

To cite this article:

Dynin PS, Litvinenko IV, Frunza DN, Ruban AV. Higher-level ambulation disorders in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(11‑2):32‑38. (In Russ.)
https://doi.org/10.17116/jnevro202512511232

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Effe­cts of rhythmic transcranial magnetic stimulation in the treatment of inso­mnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):64-69
The main mechanisms of deve­lopment of cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):13-18
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Cognitive impairment after major surgical operations. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):74-80
Sleep diso­rders in patients with Lewy body deme­ntia and Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):81-87
Study of the levo­carnitine effi­cacy for the treatment of mode­rate cognitive impairment in patients with hype­rtension. Russian Journal of Preventive Medi­cine. 2025;(4):45-50
Art and creativity in Parkinson’s disease: the mysterious effe­cts of dopa­mine. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):13-20
Correlation of motor symptoms and cardiovascular dysfunction in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):59-67
Pote­ntial of animal-derived neuropeptides in complex therapy of diabetic neuropathy in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):83-87
Diagnosis of pathological and adaptive bala­nce changes in Parkinson’s disease to select a reha­bilitation program. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):88-94
Abstract:

The article discusses ambulation disorders in Parkinson’s disease, which result from both disease progression and aging. It focuses on multisensory impairments and the critical link between cognitive and motor disorders, particularly the motor-cognitive deficit. Diagnosing ambulation disorders presents several challenges because it’s essential to identify the specific cause in each case. Key factors include the ineffectiveness of standard antiparkinsonian therapy, varying degrees of cognitive impairments (including visual and spatial difficulties), and the presence of comorbidities. The potential role of changes in gait patterns and motor activity as a marker for the progression of cognitive deficits is discussed. The use of modern techniques in complex diagnostics and therapy for assessing and treating higher-level ambulation disorders in Parkinson’s disease is discussed. The author’s data underscore the importance of combining both drug and non-drug methods in the treatment of advanced ambulation disorders in Parkinson’s disease. This includes the use of transcranial magnetic stimulation, interactive ergometric exercises, and anticholinesterase agents.

Keywords:

Parkinson’s disease
higher-level ambulation disorders
cognitive impairment
transcranial magnetic stimulation
postural balance
non-drug therapy
anticholinesterase therapy

Authors:

Dynin P.S.

Kirov Military Medical Academy

Litvinenko I.V.

Kirov Military Medical Academy

Frunza D.N.

S.M. Kirov Military Medical Academy

Ruban A.V.

S.M. Kirov Military Medical Academy

Received:

02.08.2025

Accepted:

08.08.2025

Close metadata

References:

  1. Pei-Hao C, Rong-Long W, De-Jyun L, et al. Gait Disorders in Parkinson’s Disease Assessment and Management. International Journal of Gerontology. 2013;7(4):189-193.  https://doi.org/10.1016/j.ijge.2013.03.005
  2. Amosova NA, Artem’ev DV, Bogdanov RR, et al. Rukovodstvo po diagnostike i lecheniyu bolezni Parkinsona. Pod red. Illarioshkina S.N., Levina O.S. M.: OOO «IPK Pareto-Print», 2017 (In Russ.).
  3. Mirelman A, Bonato P, Camicioli R, et al. Gait impairments in Parkinson’s disease. Lancet Neurology. 2019;18(7):697-708.  https://doi.org/10.1016/S1474-4422(19)30044-4
  4. Miliukhina IV, Gracheva EV. Modern views on gait impairment in Parkinson`s disease and its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(6):96-101. (In Russ.). https://doi.org/10.17116/jnevro20181186196
  5. Litvinenko IV, Khalimov RR, Trufanov AG, et al. New approach to gait disorders therapy in late stages of Parkinson’s disease. Uspehi gerontologii. 2012;25(2):267-74. (In Russ.).
  6. Tran TN, Vo TNN, Frei K, et al. Levodopa-induced dyskinesia: clinical features, incidence, and risk factors. Journal of Neural Transmission. 2018;125(8):1109-1117. https://doi.org/10.1007/s00702-018-1900-6
  7. Lobzin VYu, Alizade MR, Lapina AV, et al. Idiopathic normal pressure hydrocephalus and Alzheimer’s disease in clinical practice: comorbidity and differentiation. Medicinskij alfavit. 2020;22:36-43. (In Russ.). https://doi.org/10.33667/2078-5631-2020-22-36-43
  8. Shin HW, Hong SW, Youn, et al. Clinical Aspects of the Differential Diagnosis of Parkinson’s Disease and Parkinsonism. Journal of Clinical Neurology. 2020;18(3):259-270.  https://doi.org/10.3988/jcn.2022.18.3.259
  9. Nonnekes J, Bereau M, Bloem BR. Freezing of Gait and Its Levodopa Paradox. JAMA neurology. 2020;77(3):287-288.  https://doi.org/10.1001/jamaneurol.2019.4006
  10. Vale TC, Pedroso JL, Barsottini OG, et al. A Brazilian Football Player Still on the Pitch After 10 Years of Parkinson’s Disease with Severe Freezing of Gait. Movement Disorders Clinical Practice. 2014;2(1):43-44.  https://doi.org/10.1002/mdc3.12110
  11. Skripkina NA, Levin OS. Gait disorders in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. Specvypuski. 2015;115(6-2):54-60. (In Russ.). https://doi.org/10.17116/jnevro20151156254-60
  12. Jansen JAF, Capato TTC, Darweesh SKL, et al. Exploring the levodopa-paradox of freezing of gait in dopaminergic medication-naïve Parkinson’s disease populations. NPJ Parkinson’s Disease. 2023;9(1):130.  https://doi.org/10.1038/s41531-023-00575-0
  13. Kim SJ, Paeng SH, Kang SY. Stimulation in Supplementary Motor Area Versus Motor Cortex for Freezing of Gait in Parkinson’s Disease. Journal of Clinical Neurology. 2018;14(3):320-326.  https://doi.org/10.3988/jcn.2018.14.3.320
  14. Brugger F, Wegener R, Baty F, et al. Facilitatory rTMS over the Supplementary Motor Cortex Impedes Gait Performance in Parkinson Patients with Freezing of Gait. Brain Sciences. 2021;11(3):321.  https://doi.org/10.3390/brainsci11030321
  15. Ray NJ, Kanel P, Bohnen NI. Atrophy of the Cholinergic Basal Forebrain can Detect Presynaptic Cholinergic Loss in Parkinson’s Disease. Annals of Neurology. 2023;93(5):991-998.  https://doi.org/10.1002/ana.26596
  16. Xu SS, Zhu SG, Yuan CX, et al. Case report: Levodopa challenge test is important in identifying dopamine-induced freezing of gait in patient with Parkinson’s disease. Frontiers in Human Neuroscience. 2024;18:1464152. https://doi.org/10.3389/fnhum.2024.1464152
  17. di Biase L, Pecoraro PM, Carbone SP, et al. Levodopa-Induced Dyskinesias in Parkinson’s Disease: An Overview on Pathophysiology, Clinical Manifestations, Therapy Management Strategies and Future Directions. Journal of Clinical Medicine. 2023;12(13):4427. https://doi.org/10.3390/jcm12134427
  18. Chambers NE, Coyle M, Sergio J, et al. Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats. European Journal of Neuroscience. 2021;53(8):2835-2847. https://doi.org/10.1111/ejn.15106
  19. Skripkina NA, Freezing phenomenon in Parkinsonism. Bjulleten’ Nacional’nogo obshhestva po izucheniju bolezni Parkinsona i rasstrojstv dvizhenij. 2022;2:184-187. (In Russ.). https://doi.org/10.17116/jnevro20151156254-60
  20. Litvinenko IV, Naumov KM. Multisensory disorders in neurodegenerative diseases related to aging. Izvestiya Rossijskoj Voenno-Medicinskoj Akademii. 2022;41(4):415-420. (In Russ.). https://doi.org/10.17816/rmmar111855
  21. Folstein MF, Folstein SE, McHugh PR. «Mini-mental state». A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975;12(3):189-198.  https://doi.org/10.1016/0022-3956(75)90026-6
  22. Dubois B, Slachevsky A, Litvan I, et al. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55(11):1621-1626. https://doi.org/10.1212/wnl.55.11.1621
  23. Martinez-Martin P. Dementia in Parkinson’s disease: usefulness of the pill questionnaire. Movement disorders: Official Journal of the Movement Disorder Society. 2013;28(13):1832-1837. https://doi.org/10.1002/mds.25649
  24. Litvan I, Goldman JG, Tröster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Movement disorders: official journal of the Movement Disorder Society. 2012;27(3):349-356.  https://doi.org/10.1002/mds.24893
  25. Pagano G, Rengo G, Pasqualetti G, et al. Cholinesterase inhibitors for Parkinson’s disease: a systematic review and meta-analysis. Journal of neurology, neurosurgery, and psychiatry. 2015;86(7):767-773.  https://doi.org/10.1136/jnnp-2014-308764
  26. Podsiadlo D, Richardson S. The timed «Up & Go»: a test of basic functional mobility for frail elderly persons. Journal of the American Geriatrics Society. 1991;39(2):142-148.  https://doi.org/10.1111/j.1532-5415.1991.tb01616.x
  27. Lindholm B, Nilsson MH, Hansson O, et al. The clinical significance of 10-m walk test standardizations in Parkinson’s disease. Journal of Neurology. 2018;265(8):1829-1835. https://doi.org/10.1007/s00415-018-8921-9
  28. Pokhabov DV, Abramov VG, Nesterova YuV. Walking disturbances at the Parkinsonism. New possibilities in the diagnosis, treatment and neyroprotection. Bulleten sibirskoy mediciny. 2011;10(2):147-153. (In Russ.). https://doi.org/10.20538/1682-0363-2011-2-147-153
  29. Bougea A. Digital biomarkers in Parkinson’s disease. Advances in Clinical Chemistry. 2024;123:221-253.  https://doi.org/10.1016/bs.acc.2024.06.005
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.